RhumbLine Advisers
ZLAB icon

RhumbLine Advisers’s Zai Lab ZLAB Stock Holding History

RhumbLine Advisers’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$94 – 4269
2026
Q1 		$94 Sell
5
-276
-98% -$5.12K ﹤0.01% 4053
2025
Q4 		$4.96K Sell
281
-10
-3% -$234 ﹤0.01% 3923
2025
Q3 		$9.86K Sell
291
-27
-8% -$930 ﹤0.01% 3855
2025
Q2 		$11.1K Buy
318
+55
+21% +$1.81K ﹤0.01% 3858
2025
Q1 		$9.5K Sell
263
-1,977
-88% -$60.8K ﹤0.01% 3842
2024
Q4 		$58.7K Buy
2,240
+25
+1% +$694 ﹤0.01% 3617
2024
Q3 		$53.5K Sell
2,215
-40
-2% -$756 ﹤0.01% 3668
2024
Q2 		$39.1K Sell
2,255
-177
-7% -$3.11K ﹤0.01% 3745
2024
Q1 		$39K Buy
2,432
+1,019
+72% +$21.5K ﹤0.01% 3680
2023
Q4 		$38.6K Sell
1,413
-3,280
-70% -$86.6K ﹤0.01% 3678
2023
Q3 		$114K Buy
4,693
+42
+0.9% +$1.12K ﹤0.01% 3421
2023
Q2 		$129K Buy
+4,651
New +$152K ﹤0.01% 3427

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

RhumbLine Advisers's ZLAB Position: Q2 2026 in Review

RhumbLine Advisers sold out of Zai Lab (ZLAB) in Q2 2026, closing a stake of 5 shares — an estimated $94 sold.

RhumbLine Advisers first reported a position in ZLAB in Q2 2023 and held it in 12 quarters. The position peaked at $129K in Q2 2023. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • RhumbLine Advisers reported no remaining Zai Lab position as of Q2 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 5 Zai Lab shares in Q2 2026, an estimated $94.
  • RhumbLine Advisers first reported a position in Zai Lab in Q2 2023 and held it in 12 quarters.
  • RhumbLine Advisers's Zai Lab position peaked at $129K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.